Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

FluMist® (influenza vaccine live) – Self-administration approval

September 20, 2024 - The FDA announced the approval of AstraZeneca’s FluMist (influenza vaccine live) intranasal spray, for self- or caregiver-administration.

Download PDF

Rx navigation